Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-24
1994-01-18
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 93, 546 94, C07D45100, C07D47100, A61K 3141, A61K 31435
Patent
active
052800288
ABSTRACT:
This invention relates to compounds useful in treating HT.sub.4 and/or HT.sub.3 mediated conditions of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen, alkoxy, halogen, amino, monoalkylamino, dialkylamino, acylamino and alkylsulfonylamino; R.sub.3 is selected from the group consisting of H, alkyl and cycloalkyl; X is NH or O; Z is selected from the group consisting of ##STR2## n and r are independently 1 or 2; p is 0 or 1; pharmaceutical compositions containing the compounds and a method for treating serotonin mediated condition with the compositions which act as 5-HT.sub.4 agonists or antagonists and/or 5-HT.sub.3 antagonists.
REFERENCES:
patent: 4083985 (1978-04-01), Cohen et al.
patent: 5137893 (1992-08-01), Becker et al.
patent: 5140023 (1992-08-01), Becker et al.
Schiantarelli et al. Pharmacological Research 22, Supp. 2 453 Jan. 1990.
A. Dumuis et al. Azabicycloalkylbenzimidazolone derivatives as etc. Naunyn-Schmiedeberg;s Arch Pharmacol 343 245-251 Jan. 1991.
M. Turconi et al. Synthesis of a New Class of etc. J. Med. Chem. 33, No. 8 2101-2108 Jan. 1990.
Flynn Daniel L.
Moormann Alan E.
G. D. Searle & Co.
Ivy C. Warren
Kovacevic Cynthia S.
Spivack Phyllis G.
Williams Roger A.
LandOfFree
Benzimidazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1136526